(Q34458235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

meta-analysis

0 references

title

Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Marina Pollan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Trinidad Dierssen-Sotos

4

object named as

Trinidad Dierssen-Sotos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

María de Pedro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sara Baeza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

María-Teresa Escudero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Javier Llorca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

15 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

525-536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25589172%20AND%20SRC:MED&resulttype=core&format=json

The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

The role of cyclooxygenase-2 in breast cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal Anti-inflammatory Drugs and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal antiinflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association of regular aspirin use and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Long-term aspirin use and mortality in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Medication use and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Low-dose aspirin use and cancer characteristics: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Prospective study of regular aspirin use and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

NSAID use and breast cancer risk in the VITAL cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Regular aspirin use and breast cancer risk in US Black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Aspirin and cancer risk: an updated quantitative review to 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Aspirin and cancer risk: a quantitative review to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Breast cancer and NSAID use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Aspirin use and breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3267-9